Related Experiment Video
Updated: May 23, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
International Consensus on Severe Lung Cancer-The Second Edition.
Xinqing Lin1, Qian Chu2, Yuchao Dong3
1Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
This updated consensus provides a practical framework for managing severe lung cancer, emphasizing precise detection, life support, novel therapies, and multidisciplinary team (MDT) guidance for patients with performance status (PS) 2-4.
Area of Science:
- Oncology
- Pulmonology
- Critical Care Medicine
Background:
- Global attention to severe lung cancer patients (PS 2-4) has increased since the 2021 consensus.
- Novel therapies, interventional techniques, and supportive care have expanded treatment options.
- This consensus is an update to incorporate recent advances and real-world data.
Purpose of the Study:
- To update the international consensus on severe lung cancer management.
- To provide a practical framework for clinicians treating patients with PS 2-4.
Main Methods:
- A multidisciplinary panel of experts reviewed current evidence on severe lung cancer.
- The panel engaged in thorough discussions to reach consensus.
- 11 recommendations were developed with over 70% expert agreement.
Main Results:
- Consensus points cover definition, causes, assessment, general strategies, and specific treatment modalities.
- Emphasis is placed on dynamic detection, life support, flexible novel therapy application, and MDT-guided adjustments.
- Early rehabilitation and comprehensive supportive care are highlighted as integral.
Conclusions:
- The updated consensus provides a practical framework for clinicians based on current evidence and expert agreement.
- Prospective trials specifically for severe lung cancer patients are urgently needed.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease II: Emphysema
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-I: Introduction